Auron Therapeutics
Latest round
- Series B
Last raised
- Dec 2024
Total raised
- $52M
Investors
- 12
About Auron Therapeutics
Founded in 2018 and based in Massachusetts, US, Auron Therapeutics, Inc. operates as a developer of therapeutic medicine that could help cure individuals with cancer whether it's solid or hematological tumors. In December 2024, Auron Therapeutics, Inc. The company aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to the transformation of malignant cells into more normal functioning cells.
Who invested in Auron Therapeutics
12 investors across 3 rounds
See all investors in Auron Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Auron Therapeutics
Who invested in Auron Therapeutics?
Auron Therapeutics has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Auron Therapeutics raised?
Auron Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Auron Therapeutics last raise money?
Auron Therapeutics's most recent round on record is a Series B, in Dec 2024.
What does Auron Therapeutics do?
Founded in 2018 and based in Massachusetts, US, Auron Therapeutics, Inc.
Where is Auron Therapeutics headquartered?
Auron Therapeutics is headquartered in Newton, US.
Which VCs invest in companies like Auron Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Auron Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Auron Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.